Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
International Journal of Geriatric Psychiatry|March 18, 2022
Assessment of autonomic symptoms may assist with early identification of mild cognitive impairment with Lewy bodiesCalum A Hamilton, James Frith, Paul C Donaghy, et al.
Pilot and Feasibility Studies|September 27, 2025
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): results from an internal pilot randomised controlled trialHelen Mossop, Sarah Al-Ashmori, Tumi Sotire, et al.
Oncotarget|April 15, 2015
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohortJérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Atherosclerosis|April 23, 2021
Improving the identification of patients with a genetic diagnosis of familial hypercholesterolaemia in primary care: A strategy to achieve the NHS long term planLorna Ingoe, Aimee Potter, Susan Musson, et al.
Journal of the American Academy of Dermatology|January 17, 2015
Histologic features of melanoma associated with CDKN2A genotypeMichael R Sargen, Peter A Kanetsky, Julia Newton-Bishop, et al.
International Journal of Geriatric Psychiatry|April 7, 2022
Blood pressure and heart rate responses to orthostatic challenge and Valsalva manoeuvre in mild cognitive impairment with Lewy bodiesCalum A Hamilton, James Frith, Paul C Donaghy, et al.
BMC Cardiovascular Disorders|November 8, 2018
Trial of exercise to prevent HypeRtension in young adults (TEPHRA) a randomized controlled trial: study protocolWilby Williamson, Odaro J Huckstep, Eleni Frangou, et al.
The Journal of Investigative Dermatology|April 7, 2024
Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary MelanomaJuliette Randerson-Moor, John Davies, Mark Harland, et al.
Pigment Cell & Melanoma Research|October 30, 2019
MX 2 is a novel regulator of cell cycle in melanoma cellsMarina Juraleviciute, Joanna Pozniak, Jérémie Nsengimana, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 2, 2024
Peroxiredoxin-2 represses NRAS-mutated melanoma cells invasion by modulating EMT markersIsabella Harumi Yonehara Noma, Larissa Anastacio da Costa Carvalho, Denisse Esther Mallaupoma Camarena, et al.
Pageof 20